CJC-1295 No DAC and Ipamorelin: Research Tendon Considerations

CJC-1295 no DAC and ipamorelin are studied together in growth hormone axis research because they engage two different receptors rather than one, and tendon interest in that literature traces downstream — to IGF-1 signaling and collagen synthesis markers examined in preclinical connective tissue models. The evidence base is largely in vitro and animal work, and it does not support claims about outcomes in people. For a business evaluating whether to stock either compound, the decision turns on analytical documentation — purity, identity, batch-level testing, and whether the certificate of analysis can actually be verified — not on research findings. Both are research-use-only compounds, and Real Peptides does not publish dosing, reconstitution, or administration guidance for any item in its catalog.

Two receptors, one endocrine axis

CJC-1295 without DAC, often labeled modified GRF (1-29), is a synthetic analogue of the first 29 amino acids of growth hormone releasing hormone, with amino acid substitutions intended to slow enzymatic degradation. The DAC variant carries a drug affinity complex that binds serum albumin and extends circulation time; the no-DAC form omits it. That single structural difference is why the two are distinct SKUs with distinct research applications, and why a supplier that lists "CJC-1295" without specifying DAC status is giving you an incomplete product description before you have even looked at the lab work.

Ipamorelin is a pentapeptide that acts at the growth hormone secretagogue receptor — the ghrelin receptor — and is characterized in published work as relatively selective compared with earlier secretagogues studied in that class. Because the two compounds act at separate receptors, research groups frequently examine them in combination to study whether the signals are additive at the somatotroph level.

For a catalog buyer, the practical takeaway is narrower than the pharmacology. These are commonly requested together, they are commonly ordered together, and lot-to-lot consistency across a paired SKU matters more than it does for a standalone item. If your reorder of one arrives from a different manufacturing lot with a different impurity profile than the last, a research customer comparing results across batches will notice before you do.

Why tendon shows up in the literature at all

Tendon is an unusual tissue to study. It is dense type I collagen with sparse vascularity, a low cell count relative to matrix volume, and slow turnover compared with muscle or skin. Those properties are precisely what make it a recurring subject in connective tissue research: changes are measurable, slow, and structurally consequential.

The growth hormone axis enters that research because studies report associations between GH signaling, circulating and locally expressed IGF-1, and collagen synthesis activity in tenocytes and surrounding matrix. Research suggests the relationship is more complex than a simple dose-response — matrix organization, mechanical loading, and local growth factor expression all appear in the same models, and separating one variable from the others is the hard part of the work.

What the literature does not support is a claim that any secretagogue produces a particular structural outcome. Much of the relevant data comes from cell culture and animal models, findings are not uniformly consistent across study designs, and translation to any clinical claim is not established. A wholesale supplier that markets these compounds with tendon outcome language is telling you something about its compliance posture, not about the science.

Buyers serving connective tissue research groups often see the same customers requesting adjacent compounds — BPC-157 and TB-500 appear in tissue signaling literature for separate mechanistic reasons — which is a catalog planning consideration rather than a scientific one.

What has to be on the certificate of analysis

Purity is the number everyone quotes and the least informative one in isolation. A purity figure means something only alongside the method that produced it and the batch it describes. The documentation worth demanding covers several distinct questions:

Identity. Mass spectrometry confirming the molecular weight matches the stated sequence. Purity without identity tells you the vial contains 99% of something.

Purity by HPLC. With the chromatogram, not just a summary figure. The trace shows where impurity peaks sit.

Peptide content versus gross weight. Lyophilized material includes counterions and residual water. Net peptide content is a separate measurement from vial fill weight, and suppliers who conflate them are quietly shipping less than the label implies.

Contamination panels. Endotoxin, bioburden or sterility, residual solvents from synthesis, heavy metals, and water content by Karl Fischer. These are the tests most often absent from a thin one-page COA.

Lot traceability. The certificate must name the batch, and the batch number must appear on the vial you receive. A COA that describes a representative lot rather than your lot is a marketing document.

Supplier due diligence, question by question

How wholesale terms in this category actually work

Research peptide wholesale programs generally price on volume, sometimes on category mix, and occasionally on order value rather than unit count. Minimums may be set per SKU, per order, or as a first-order threshold followed by lower reorder minimums. Margins and minimums vary widely by compound, synthesis complexity, and volume commitment, and any supplier quoting you a universal industry figure is guessing.

What matters more than the headline discount is what the number excludes. Ask whether testing documentation carries a cost, whether cold-chain shipping is billed separately, whether private-label or custom-labeled runs change the minimum, and whether tier pricing resets each ordering period. A program with a modest published discount and no hidden line items is usually cheaper in practice than an aggressive quoted rate that adds fees at checkout.

Also ask about lot consistency across reorders. A supplier that cannot tell you whether your next order ships from the same manufacturing campaign is asking you to absorb variability your customers will attribute to you, not to them.

The compliance questions to route through your counsel

This section is informational and is not legal advice. Research-use-only compounds sit in a regulatory context that differs by business model and by jurisdiction, and the answers belong to your attorney and your state board, not to a supplier's blog.

The questions worth putting in front of counsel generally include: how research-use-only labeling must appear on product you resell; whether your business structure and licensure permit resale of these materials at all in the states where you operate; what your customer verification obligations look like; how import, storage, and recordkeeping requirements apply to your operation; and what your advertising is permitted to say. Ask specifically what your catalog copy may and may not claim, because that is where most avoidable exposure lives.

On the copy itself, the durable discipline is simple. Product pages describe the compound and the research, never what it does for a customer. No dosing, no reconstitution steps, no preparation walkthroughs, no unit or volume references — including converted or implied forms. Do not bundle or co-recommend supplies alongside compounds. Where a research customer asks about concentration, the educational ceiling is the concentration framework itself: milligrams of peptide per milliliter of solvent, described as arithmetic and nothing further.

Handling, storage, and inventory mechanics

Lyophilized peptides are comparatively stable, but stability is not indefinite and it is condition-dependent. Storage guidance from the manufacturer should specify temperature range and light protection for unopened lyophilized vials, and your receiving process should confirm that shipments arrived within those conditions rather than assuming it.

Inventory practice follows from that. Rotate by lot and date rather than by shelf position. Keep the COA filed against the lot number, not against the SKU, so a customer question three months later can be answered in minutes. Record receipt condition. If you hold both CJC-1295 No DAC and Ipamorelin as paired SKUs, track them as a pair — running out of one while holding depth in the other is the most common avoidable stockout in this category.

What Real Peptides does differently

Real Peptides tests to 99%+ HPLC purity and runs a 7-panel test on every batch, and the certificates of analysis are publicly verifiable — a prospective wholesale buyer can check the lab results directly rather than requesting them, paying for them, or taking a purity figure on trust. That is the inversion of the industry pattern where documentation is gated behind an account or invoiced as an extra.

Fulfillment is US-based, with orders shipping in 5–7 days. The Wholesale Partner Program uses a 3-step application: submit the application, complete business verification, and receive tier pricing access once approved. Pricing tiers are disclosed to approved partners rather than quoted ad hoc, so a buyer can model cost per unit before committing to volume.

Every compound in the catalog, including the two discussed here, is supplied for research use only and is not an FDA-approved drug or a product for human consumption. No preparation, dosing, or administration guidance is provided with any order, by design.

Deciding whether this pairing belongs in your catalog

If your customers are research groups working in connective tissue or endocrine signaling, this pairing is a reasonable catalog addition — provided your supplier's documentation survives the questions in the table above and your counsel has cleared your resale position. Businesses ready to evaluate tier pricing and batch documentation can begin the Wholesale Partner Program application at realpeptides.co and review verification results before placing a first order.

Buyers building depth around tissue signaling can review the Growth Factor & Tissue Signaling Research and Performance & Recovery Research collections, or start from the Popular Peptides range to see how the same testing standard applies across the catalog.